Five-Year Survival Outcomes With Nivolumab Plus Ipilimumab Versus Chemotherapy as First-Line Treatment for Metastatic Non–Small-Cell Lung Cancer in CheckMate 227.

Details

Language :

English

ISSN :

0732183X

Volume :

41

Issue :

6

Database :

Supplemental Index

Journal :

Journal of Clinical Oncology

Publication Type :

Academic Journal

Accession number :

161906940

Full Text :

https://doi.org/10.1200/JCO.22.01503